Literature DB >> 8059728

Incidence of myocarditis in peripartum cardiomyopathy.

M N Rizeq1, P R Rickenbacher, M B Fowler, M E Billingham.   

Abstract

Peripartum cardiomyopathy (PC), an uncommon cause of peripartum heart failure, is defined as a cardiomyopathy presenting in the last trimester of pregnancy or the first 6 months postpartum, without evidence of preexisting cardiovascular disease. The etiology of PC and idiopathic dilated cardiomyopathy (IDC) remains uncertain. Several reports have addressed possible differences in clinical presentation and prognosis between these groups. A relatively high incidence of myocarditis has been recently reported in patients with PC, raising the possibility that this may represent a distinct difference between this condition and IDC. A retrospective review of endomyocardial biopsy specimens from 34 patients fulfilling the criteria for a diagnosis of PC was therefore performed to further evaluate this finding. Results indicate a lower incidence of myocarditis (8.8%, 3 of 34) than that reported in other studies. This incidence was comparable to that found in an age- and sex-matched control population undergoing transplantation for IDC (9.1%, 2 of 22). Factors that may influence the diverse range in the reported incidence of myocarditis are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 8059728     DOI: 10.1016/0002-9149(94)90906-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

1.  African-American women have a higher risk for developing peripartum cardiomyopathy.

Authors:  Mindy B Gentry; James K Dias; Antonio Luis; Rakesh Patel; John Thornton; Guy L Reed
Journal:  J Am Coll Cardiol       Date:  2010-02-16       Impact factor: 24.094

2.  Emergency management of decompensated peripartum cardiomyopathy.

Authors:  Indu Lata; Renu Gupta; Sandeep Sahu; Harpreet Singh
Journal:  J Emerg Trauma Shock       Date:  2009-05

Review 3.  The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.

Authors:  Jonathan G Howlett; Robert S McKelvie; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Simon Kouz; Kori Leblanc; Peter Liu; Elizabeth Mann; Gordon W Moe; Eileen O'Meara; Miroslav Rajda; Samuel Siu; Paul Stolee; Elizabeth Swiggum; Shelley Zeiroth
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

Review 4.  Peripartum cardiomyopathy.

Authors:  Lori A Blauwet; Karen Sliwa
Journal:  Obstet Med       Date:  2011-05-12

Review 5.  A contemporary review of peripartum cardiomyopathy.

Authors:  Peysh A Patel; Ashwin Roy; Rabeia Javid; John Aw Dalton
Journal:  Clin Med (Lond)       Date:  2017-07       Impact factor: 2.659

Review 6.  Peripartum cardiomyopathy: a review.

Authors:  Anirban Bhattacharyya; Sukhdeep Singh Basra; Priyanka Sen; Biswajit Kar
Journal:  Tex Heart Inst J       Date:  2012

Review 7.  Interventions for treating peripartum cardiomyopathy to improve outcomes for women and babies.

Authors:  Andrew J Carlin; Zarko Alfirevic; Gillian Ml Gyte
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 8.  Management of peripartum cardiomyopathy.

Authors:  Karen Sliwa; Kemi Tibazarwa; Denise Hilfiker-Kleiner
Journal:  Curr Heart Fail Rep       Date:  2008-12

9.  Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging.

Authors:  Frederic Mouquet; Christophe Lions; Pascal de Groote; Nadia Bouabdallaoui; Serge Willoteaux; Joel Dagorn; Philippe Deruelle; Nicolas Lamblin; Christophe Bauters; Jean Paul Beregi
Journal:  Eur Radiol       Date:  2008-07-19       Impact factor: 5.315

Review 10.  Peripartum cardiomyopathy: review of the literature.

Authors:  Pradipta Bhakta; Binay K Biswas; Basudeb Banerjee
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.